These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10621810)

  • 1. Levomepromazine (methotrimeprazine) and the last 48 hours.
    O'Neill J; Fountain A
    Hosp Med; 1999 Aug; 60(8):564-7. PubMed ID: 10621810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Little effects of low dosage of levomepromazine on plasma risperidone levels.
    Yoshimura R; Shinkai K; Kakihara S; Goto M; Yamada Y; Kaji K; Ueda N; Nakamura J
    Pharmacopsychiatry; 2005 Mar; 38(2):98-100. PubMed ID: 15744635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How is agitation and restlessness managed in the last 24 h of life in patients whose care is supported by the Liverpool care pathway for the dying patient?
    Gambles M; McGlinchey T; Latten R; Dickman A; Lowe D; Ellershaw JE
    BMJ Support Palliat Care; 2011 Dec; 1(3):329-33. PubMed ID: 24653479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levomepromazine for schizophrenia.
    Sivaraman P; Rattehalli R; Jayaram M
    Schizophr Bull; 2012 Mar; 38(2):219-20. PubMed ID: 22114097
    [No Abstract]   [Full Text] [Related]  

  • 5. Focus on levomepromazine.
    Green B; Pettit T; Faith L; Seaton K
    Curr Med Res Opin; 2004 Dec; 20(12):1877-81. PubMed ID: 15701205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit.
    Schildmann E; Pörnbacher S; Kalies H; Bausewein C
    Palliat Med; 2018 Jul; 32(7):1189-1197. PubMed ID: 29557260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia.
    Higashima M; Takeda T; Nagasawa T; Hirao N; Oka T; Nakamura M; Kitamura M; Koshino Y
    Eur Psychiatry; 2004 Sep; 19(6):380-1. PubMed ID: 15363480
    [No Abstract]   [Full Text] [Related]  

  • 8. A naturalistic comparison study of the efficacy and safety of intramuscular olanzapine, intramuscular haloperidol, and intramuscular levomepromazine in acute agitated patients with schizophrenia.
    Suzuki H; Gen K; Takahashi Y
    Hum Psychopharmacol; 2014 Jan; 29(1):83-8. PubMed ID: 24424709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.
    Kornhuber J; Wiltfang J; Riederer P; Bleich S
    Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):274-80. PubMed ID: 16788768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrimeprazine for the management of end-of-life symptoms in infants and children.
    Hohl CM; Stenekes S; Harlos MS; Shepherd E; McClement S; Chochinov HM
    J Palliat Care; 2013; 29(3):178-85. PubMed ID: 24380217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levomepromazine-induced lupus?
    Fletcher AJ
    J Pain Symptom Manage; 2009 Jun; 37(6):e1-2. PubMed ID: 19500717
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-apomorphine effects of phenothiazine drug metabolites.
    Morel E; Lloyd KG; Dahl SG
    Psychopharmacology (Berl); 1987; 92(1):68-72. PubMed ID: 2885882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levomepromazine helps to reduce sleep problems in patients with PTSD.
    Aukst-Margetić B; Margetić B; Tosić G; Bilić-Prcić A
    Eur Psychiatry; 2004 Jun; 19(4):235-6. PubMed ID: 15196608
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed-onset nocturnal akathisia due to risperidone and levomepromazine: a case report.
    Shimizu E; Watanabe H; Iyo M
    Eur Psychiatry; 2002 Sep; 17(5):294-5. PubMed ID: 12381501
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of stuttering during treatment with levomepromazine.
    Margetic B; Aukst-Margetic B; Krajinovic B
    Psychopharmacol Bull; 2009; 42(1):8-10. PubMed ID: 19204648
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life.
    Kawashima N; Yokomichi N; Morita T; Yabuki R; Hisanaga T; Imai K; Hirose Y; Shimokawa M; Miwa S; Yamauchi T; Okamoto S; Satomi E
    J Pain Symptom Manage; 2024 May; 67(5):441-452.e3. PubMed ID: 38355071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.
    Fuglum E; Schillinger A; Andersen JB; Belstad BE; Jensen D; Müller F; Müller KJ; Schulstad B; Elgen K
    Pharmatherapeutica; 1989; 5(5):285-91. PubMed ID: 2568639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrimeprazine in the treatment of agitation in acquired brain injury patients.
    Maryniak O; Manchanda R; Velani A
    Brain Inj; 2001 Feb; 15(2):167-74. PubMed ID: 11260766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levomepromazine for nausea and vomiting in palliative care.
    Cox L; Darvill E; Dorman S
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009420. PubMed ID: 26524693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsustained ventricular tachycardia in a patient with acquired long QT syndrome after levomepromazine injection.
    Preßler J; Lücking M; Melter M; Gerling S
    Intensive Care Med; 2014 Jan; 40(1):133-4. PubMed ID: 24170144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.